Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study

@article{Hill2016ClinicalTF,
  title={Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study},
  author={S. Hill and J. Najafi and M. Dunn and P. Acheampong and A. Kamour and J. Grundlingh and P. Blain and S. Thomas},
  journal={Clinical Toxicology},
  year={2016},
  volume={54},
  pages={638 - 643}
}
  • S. Hill, J. Najafi, +5 authors S. Thomas
  • Published 2016
  • Medicine
  • Clinical Toxicology
    • Abstract Context: Recreational use of Synthetic Cannabinoid Receptors Agonists (SCRAs) has become increasingly common in many countries and may cause severe toxic effects. Objective: To describe the clinical features of toxicity in seven men after analytically confirmed exposure to MDMB-CHMICA, a recently described indole-based SCRA. Materials and methods: Clinical information and biological samples (blood, urine) were collected from patients with severe toxicity after suspected use of novel… CONTINUE READING
    View on Taylor & Francis
    eprint.ncl.ac.uk
    Top 3 of 31 Citations
    Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015
    Rachelle Abouchedid, S. Hudson, … P. DarganClinical toxicology2017
    26
    Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study
    J. White, D. Wood, … S. ThomasClinical toxicology2019
    2
    Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA
    M. Hermanns-Clausen, D. Müller, … V. AuwärterClinical toxicology2018
    24
    31 Citations
    Citation Type

    Citation Type

    Analytical confirmation of synthetic cannabinoids in a cohort of 179 presentations with acute recreational drug toxicity to an Emergency Department in London, UK in the first half of 2015
    • 26
    Acute toxicity following analytically confirmed use of the novel psychoactive substance (NPS) methiopropamine. A report from the Identification of Novel psychoActive substances (IONA) study
    • 2
    Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICA
    • 24
    Analytically Confirmed Intoxications Involving MDMB-CHMICA from the STRIDA Project
    • 40
    • PDF
    Human Toxicity Caused by Indole and Indazole Carboxylate Synthetic Cannabinoid Receptor Agonists: From Horizon Scanning to Notification.
    • 8
    • PDF
    A case of 5F-ADB / FUB-AMB abuse: Drug-induced or drug-related death?
    • 4
    Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxication
    • 8
    Poisoning due to MDMB-CHMICA, a synthetic cannabinoid receptor agonist
    • 6
    Phase I metabolism of the highly potent synthetic cannabinoid MDMB-CHMICA and detection in human urine samples.
    • 46
    Synthetic cannabinoid receptor agonists: classification and nomenclature
    • 4

    References

    Publications referenced by this paper.
    SHOWING 1-10 OF 16 REFERENCES
    Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists: a report from the United Kingdom National Poisons Information Service
    • 39
    • PDF
    Fatal intoxication with synthetic cannabinoid MDMB-CHMICA.
    • 56
    A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment
    • 187
    • PDF
    Central effects of the cannabinoid receptor agonist WIN55212‐2 on respiratory and cardiovascular regulation in anaesthetised rats
    • 44
    Synthetic Cannabinoid-Related Illnesses and Deaths.
    • 176
    • PDF
    Hospitalisation from synthetic cannabinoid MMB CHMINACA [Internet]; 2015 [cited 2016 May 5]. Available from: http://asfacarduf.org/wp-content/uploads/2015/07/MMB- CHMINACA-MDMB-CHMICA-alert.pdf
    • 2015
    Sudden Cardiac Death Following Use of the Synthetic Cannabinoid MDMB-CHMICA.
    • 52
    • Highly Influential
    Epidemiology and clinical features of toxicity following recreational use of synthetic cannabinoid receptor agonists. A report from the United Kingdom National Poison Information Service
    • 2016
    Hospitalisation from synthetic cannabinoid MMB CHMINACA
    • 2015
    Metabolism and urine analysis of the new synthetic cannabinoid MDMB-CHMICA
    • 2015